Gordon Findlay, a Novo Nordisk executive, suddenly collapsed while standing behind President Donald Trump at a press event inside the Oval Office. The event was held to announce a new deal related to weight-loss medications.
Findlay’s knees gave out unexpectedly, causing him to slump. White House and pharmaceutical officials immediately rushed to assist him, preventing him from hitting the floor.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, helped Findlay safely to the ground to avoid head injury. Reporters were then asked to leave the Oval Office while cabinet members attended to Findlay and elevated his legs.
White House Press Secretary Karoline Leavitt confirmed the fainting and reassured that the individual was fine and that the press conference would continue shortly.
This unexpected medical episode during a high-profile government announcement was promptly managed without serious harm.
“The person involved was okay in the end,” said Karoline Leavitt.
Author's summary: A Novo Nordisk executive fainted during a White House press event but was quickly assisted and recovered, allowing the conference to continue as planned.